Displaying 61 - 72 of 183
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Displaying 61 - 72 of 183